CN111280292A - Treatment process of collagen peptide - Google Patents
Treatment process of collagen peptide Download PDFInfo
- Publication number
- CN111280292A CN111280292A CN202010288350.8A CN202010288350A CN111280292A CN 111280292 A CN111280292 A CN 111280292A CN 202010288350 A CN202010288350 A CN 202010288350A CN 111280292 A CN111280292 A CN 111280292A
- Authority
- CN
- China
- Prior art keywords
- collagen peptide
- treatment
- oil
- process according
- peptide comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 77
- 108010035532 Collagen Proteins 0.000 title claims abstract description 77
- 229920001436 collagen Polymers 0.000 title claims abstract description 77
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000839 emulsion Substances 0.000 claims abstract description 15
- 239000008367 deionised water Substances 0.000 claims abstract description 14
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 14
- 239000002274 desiccant Substances 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 8
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- 239000004519 grease Substances 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 claims description 4
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000292 calcium oxide Substances 0.000 claims description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 235000019198 oils Nutrition 0.000 claims description 4
- -1 propylene glycol fatty acid ester Chemical class 0.000 claims description 4
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 3
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 claims description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000001593 sorbitan monooleate Substances 0.000 claims description 3
- 235000011069 sorbitan monooleate Nutrition 0.000 claims description 3
- 229940035049 sorbitan monooleate Drugs 0.000 claims description 3
- 239000001570 sorbitan monopalmitate Substances 0.000 claims description 3
- 235000011071 sorbitan monopalmitate Nutrition 0.000 claims description 3
- 229940031953 sorbitan monopalmitate Drugs 0.000 claims description 3
- 235000011078 sorbitan tristearate Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 claims description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 claims description 2
- 239000001587 sorbitan monostearate Substances 0.000 claims description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 claims description 2
- 229940035048 sorbitan monostearate Drugs 0.000 claims description 2
- 239000001589 sorbitan tristearate Substances 0.000 claims description 2
- 229960004129 sorbitan tristearate Drugs 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims 1
- 235000013772 propylene glycol Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 230000001079 digestive effect Effects 0.000 abstract description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 241000699670 Mus sp. Species 0.000 description 12
- 210000004209 hair Anatomy 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000003779 hair growth Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
- 230000002951 depilatory effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XGKPLOKHSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XGKPLOKHSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 210000002514 epidermal stem cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a treatment process of collagen peptide, which comprises the following raw materials by weight percent: 7 to 15 percent of collagen peptide, 12 to 28 percent of deionized water, 50 to 68 percent of grease or lipoid, 10 to 20 percent of emulsifier and 0.5 to 2 percent of auxiliary agent; then dissolving 7-15% of collagen peptide in 12-28% of deionized water to obtain a hydrolyzed collagen peptide solution; slowly adding the obtained hydrolyzed collagen peptide solution into 50-68% of grease or lipoid, then adding 10-20% of emulsifier and 0.5-2% of auxiliary agent, and stirring to form emulsion; and finally, adding a solid drying agent into the obtained emulsion, removing water, and filtering to obtain the required collagen peptide product. The treatment process of the collagen peptide solves the problem that the collagen peptide is easily decomposed into amino acids in digestive juice of intestinal tracts, and ensures that the collagen peptide can exist in an effective form of the protein peptide.
Description
Technical Field
The invention relates to the technical field of food processing, in particular to a treatment process of collagen peptide.
Background
Collagen plays an important role in supporting cells, and it functions not only as a connecting cell but also as a lubricant. With the aging of human body, intercellular collagen is continuously reduced and deteriorated, resulting in continuous deterioration of cells themselves. It has been found that oral administration of collagen peptides can stimulate cells, make the cells themselves more viable, and in turn, increase collagen production. Because oral collagen peptide sequentially enters the epidermal layer of the skin through small intestine-blood, one part of the oral collagen peptide is needed by the human body in the form of amino acid, and the other part of the oral collagen peptide is absorbed by the human body in the form of protein peptide (an effective form for stimulating cells) connected with amino acid, the oral collagen peptide has biological regulation function and can activate epidermal stem cells and more fibroblasts, thereby leading the cells to be more viable and delaying the skin aging. However, since collagen peptide is sensitive to digestive juice in intestinal tract and is more likely to exist in the form of amino acid, collagen peptide loses most of biological regulatory function, and the effect of activating cells is not ideal.
Therefore, there is a need to find a treatment process that allows collagen peptides to overcome the effects of digestive fluids in the intestinal tract and ultimately be absorbed by the human body in an effective form of the protein peptides.
Disclosure of Invention
The invention aims to provide a treatment process of collagen peptide, which solves the problem that the collagen peptide is easily decomposed into amino acid in digestive juice of intestinal tract and ensures that the collagen peptide can exist in an effective form of the protein peptide.
In order to achieve the above purpose, the solution of the invention is:
a treatment process of collagen peptide comprises the following steps:
step 1, weighing the following raw materials in percentage by weight:
step 2, dissolving 7-15% of collagen peptide in 12-28% of deionized water to obtain a hydrolyzed collagen peptide solution;
step 3, slowly adding the hydrolyzed collagen peptide solution obtained in the step 2 into 50-68% of grease or 50-68% of lipoid, then adding 10-20% of emulsifier and 0.5-2% of auxiliary agent, and stirring to form emulsion;
and 4, finally, adding a solid drying agent into the emulsion obtained in the step 3, removing water, and filtering to obtain the required collagen peptide product.
The oil is at least one of palm oil, peanut oil, soybean oil, rapeseed oil, sesame oil and sunflower seed oil.
The lipid is at least one of lecithin and cephalin.
The emulsifier is at least one of sorbitan monolaurate (span 20), sorbitan monopalmitate (span 40), sorbitan monostearate (span 60), sorbitan tristearate (span 65), sorbitan monooleate (span 80), propylene glycol fatty acid ester and diethylene glycol mono fatty acid ester.
The auxiliary agent is at least one of n-butyl alcohol, butanediol and glycerol.
The solid desiccant is at least one of anhydrous sodium sulfate and calcium oxide.
And 4, the mass consumption of the solid drying agent in the step 4 is 3-8 times of that of the deionized water in the step 1.
After the technical scheme is adopted, the treatment process of the collagen peptide comprises the steps of coating hydrolyzed collagen peptide by grease or lipoid under the action of an emulsifier and an auxiliary agent to form emulsion, removing water in the hydrolyzed collagen peptide by a solid drying agent to finally obtain a collagen peptide product coated by the grease or the lipoid, overcoming the defects that the collagen peptide is unstable in intestinal tracts and sensitive to digestive juice and is easy to decompose into amino acid, ensuring that the collagen peptide can exist in an effective form of the collagen peptide, and keeping the biological regulation function of the collagen peptide.
Detailed Description
In order to further explain the technical solution of the present invention, the present invention is explained in detail by the following specific examples.
First, treatment process
Example 1
A treatment process of collagen peptide comprises the following steps:
step 1, weighing the following raw materials in percentage by weight:
step 2, dissolving 10% of collagen peptide in 16% of deionized water to obtain a hydrolyzed collagen peptide solution;
step 3, slowly adding the hydrolyzed collagen peptide solution obtained in the step 2 into 60% palm oil, then adding 13% sorbitan monopalmitate and 1% n-butanol, and stirring to form emulsion;
and 4, finally, adding 3 times of anhydrous sodium sulfate in mass amount of deionized water into the emulsion obtained in the step 3, removing water, and filtering to obtain the required collagen peptide product.
Example 2
A treatment process of collagen peptide comprises the following steps:
step 1, weighing the following raw materials in percentage by weight:
step 2, dissolving 8% of collagen peptide in 15% of deionized water to obtain a hydrolyzed collagen peptide solution;
step 3, slowly adding the hydrolyzed collagen peptide solution obtained in the step 2 into 62% rapeseed oil, then adding 14% sorbitan monostearate and 1% butanediol, and stirring to form emulsion;
and 4, finally, adding calcium oxide with the mass amount being 6 times that of deionized water into the emulsion obtained in the step 3, removing water, and filtering to obtain the required collagen peptide product.
Example 3
A treatment process of collagen peptide comprises the following steps:
step 1, weighing the following raw materials in percentage by weight:
step 2, dissolving 12% of collagen peptide in 21% of deionized water to obtain a hydrolyzed collagen peptide solution;
step 3, slowly adding the hydrolyzed collagen peptide solution obtained in the step 2 into 53.5% of soybean oil, then adding 12% of sorbitan monooleate and 1.5% of glycerol, and stirring to form emulsion;
and 4, finally, adding 3 times of anhydrous sodium sulfate in mass amount of deionized water into the emulsion obtained in the step 3, removing water, and filtering to obtain the required collagen peptide product.
Example 4
A treatment process of collagen peptide comprises the following steps:
step 1, weighing the following raw materials in percentage by weight:
step 2, dissolving 9% of collagen peptide in 15% of deionized water to obtain a hydrolyzed collagen peptide solution;
step 3, slowly adding the hydrolyzed collagen peptide solution obtained in the step 2 into 60% lecithin, then adding 14% diethylene glycol monofatty acid ester and 2% glycerol, and stirring to form emulsion;
and 4, finally adding calcium oxide with the mass amount of 8 times of deionized water into the emulsion obtained in the step 3, removing water, and filtering to obtain the required collagen peptide product.
Second, description of effects
The academia generally holds that the collagen peptide can obviously improve the expression of IGF-1 (insulin-like growth factor I), and the IGF-1 is a strong mitotic cell, so that the IGF-1 can maintain the growth form of hair follicles and keep hair growth. Thus, the hair growth effect indirectly evidences the physiological utilization of collagen.
Mouse hair growth test:
randomly selecting 50 experimental mice, after the hair of the experimental mice falls off, taking the back of a blank control group of mice (10 mice in each group) and coating 0.1 ml/mouse of 50% ethanol, and taking the back of four groups of mice (10 mice in each group) and coating 0.1 ml/mouse of 0.1% testosterone for a sample coating time of 21 d.
After 21d, one group of mice was given a blank matrix of the depilatory area for 1 time/d, and is recorded as a model group, one group of mice was given a 2% minoxidil solution of the depilatory area for 1 time/d, and is recorded as a minoxidil group, one group of mice was fed with a 1 time/d common collagen peptide product, and is recorded as a common collagen group, one group of mice was fed with a 1 time/d collagen peptide product prepared in example 1, and is recorded as a collagen group, and a blank control group was given a blank matrix of the depilatory area for 1 time/d, and is continued for 21 d. In the 15 th and 20 th experiments, 10 hairs in the hair removal area on the back of each group of mice are respectively pulled out, the length of the hairs is measured and recorded by a vernier caliper under a black background, and the length of the hairs is calculated and recorded by taking the farthest distance between two ends of the hairs as the length of the hairs. The hair weight test comprises killing mice by removing neck at the end of experiment, scraping hair removed area of 3 × 3cm from back of each mouse with a blade2The area of wool was weighed on an analytical balance and averaged as listed below.
The test result shows that the collagen peptide product obtained by the invention has obvious growth effect on the mouse hair length and the mouse hair weight, and the effect is close to that of minoxidil. Therefore, the treatment process can improve the utilization rate of the collagen and has wide application prospect.
Results of the epimouse Hair growth test
The above embodiments are not intended to limit the form and style of the present invention, and any suitable changes or modifications made by those skilled in the art should be considered as not departing from the scope of the present invention.
Claims (7)
1. A treatment process of collagen peptide is characterized in that: the method comprises the following steps:
step 1, weighing the following raw materials in percentage by weight:
step 2, dissolving 7-15% of collagen peptide in 12-28% of deionized water to obtain a hydrolyzed collagen peptide solution;
step 3, slowly adding the hydrolyzed collagen peptide solution obtained in the step 2 into 50-68% of grease or 50-68% of lipoid, then adding 10-20% of emulsifier and 0.5-2% of auxiliary agent, and stirring to form emulsion;
and 4, finally, adding a solid drying agent into the emulsion obtained in the step 3, removing water, and filtering to obtain the required collagen peptide product.
2. The process according to claim 1, wherein the treatment of the collagen peptide comprises: the oil is at least one of palm oil, peanut oil, soybean oil, rapeseed oil, sesame oil and sunflower seed oil.
3. The process according to claim 1, wherein the treatment of the collagen peptide comprises: the lipid is at least one of lecithin and cephalin.
4. The process according to claim 1, wherein the treatment of the collagen peptide comprises: the emulsifier is at least one of sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan tristearate, sorbitan monooleate, propylene glycol fatty acid ester and diethylene glycol mono fatty acid ester.
5. The process according to claim 1, wherein the treatment of the collagen peptide comprises: the auxiliary agent is at least one of n-butyl alcohol, butanediol and glycerol.
6. The process according to claim 1, wherein the treatment of the collagen peptide comprises: the solid desiccant is at least one of anhydrous sodium sulfate and calcium oxide.
7. The process according to claim 1, wherein the treatment of the collagen peptide comprises: and 4, the mass consumption of the solid drying agent in the step 4 is 3-8 times of that of the deionized water in the step 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010288350.8A CN111280292A (en) | 2020-04-14 | 2020-04-14 | Treatment process of collagen peptide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010288350.8A CN111280292A (en) | 2020-04-14 | 2020-04-14 | Treatment process of collagen peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111280292A true CN111280292A (en) | 2020-06-16 |
Family
ID=71019644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010288350.8A Pending CN111280292A (en) | 2020-04-14 | 2020-04-14 | Treatment process of collagen peptide |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111280292A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102106821A (en) * | 2011-02-22 | 2011-06-29 | 四川大学 | Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments |
| JP2012116773A (en) * | 2010-11-30 | 2012-06-21 | Nippi:Kk | Igf-1 value-elevating agent |
| CN102511669A (en) * | 2011-11-21 | 2012-06-27 | 荣成百合生物技术有限公司 | Pet health food and preparation method thereof |
| CN102552138A (en) * | 2012-02-28 | 2012-07-11 | 大连医科大学 | Oral W/O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine and preparation method of same |
| CN103919255A (en) * | 2014-04-03 | 2014-07-16 | 广东润科生物工程有限公司 | Microcapsule embedding method for protein peptide |
| CN110664755A (en) * | 2019-11-06 | 2020-01-10 | 周华锋 | Protein polypeptide self-microemulsion and preparation method and application thereof |
| CN110692879A (en) * | 2019-10-12 | 2020-01-17 | 浙江英树生物科技有限公司 | Collagen peptide drink and preparation method thereof |
-
2020
- 2020-04-14 CN CN202010288350.8A patent/CN111280292A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012116773A (en) * | 2010-11-30 | 2012-06-21 | Nippi:Kk | Igf-1 value-elevating agent |
| CN102106821A (en) * | 2011-02-22 | 2011-06-29 | 四川大学 | Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments |
| CN102511669A (en) * | 2011-11-21 | 2012-06-27 | 荣成百合生物技术有限公司 | Pet health food and preparation method thereof |
| CN102552138A (en) * | 2012-02-28 | 2012-07-11 | 大连医科大学 | Oral W/O microemulsion preparation of cyclo-trans-4-hydroxyprolyl-L-serine and preparation method of same |
| CN103919255A (en) * | 2014-04-03 | 2014-07-16 | 广东润科生物工程有限公司 | Microcapsule embedding method for protein peptide |
| CN110692879A (en) * | 2019-10-12 | 2020-01-17 | 浙江英树生物科技有限公司 | Collagen peptide drink and preparation method thereof |
| CN110664755A (en) * | 2019-11-06 | 2020-01-10 | 周华锋 | Protein polypeptide self-microemulsion and preparation method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| 李磊 等: "羟丝肽口服微乳的制备与体内药动学研究", 《医药导报》 * |
| 胡雄彬等: "微乳在多肽、蛋白质类药物口服给药中的应用", 《中南药学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106214535A (en) | A kind of can the anti-apolexis composition of activating cell containing sponge micropin | |
| KR101388052B1 (en) | Composition for cosmetics comprising gluconolactone and lactobionic acid for skin exfoliation, skin whitening or improvement of skin tone | |
| JPH0661262B2 (en) | Method of stimulating cell proliferation | |
| CN115350115B (en) | Cosmetic composition comprising albumin, hyaluronic acid or collagen as active ingredient in cell culture medium | |
| CN110496067A (en) | A kind of anti-wrinkle composition and its preparation method and application | |
| CN111280292A (en) | Treatment process of collagen peptide | |
| CN105543161B (en) | Composite bio-active factor liposome and preparation method thereof | |
| CN107961198A (en) | Eye cream containing stem cell secretory factors | |
| KR101469797B1 (en) | Cosmetic composition for anti-aging containing swallow's nest extract made by using colloidal gold solution as a solvent | |
| CN110897991B (en) | Lip gloss with skin care function and preparation method thereof | |
| CA2625806C (en) | Compositions for improving skin conditions comprising human growth hormone as an active ingredient | |
| CN109966170B (en) | Flexible liposome cosmetic containing biological macromolecules and preparation method thereof | |
| EP3030253A1 (en) | Composition for improving skin conditions comprising a fragment of human heat shock protein 90a as an active ingredient | |
| KR20220052965A (en) | Skin care composition comprising mevalonolactone | |
| KR101459512B1 (en) | Cosmetic composition for hair care product that contains growth factors to devolope the regeneration of hair follicles | |
| CN104436168B (en) | Composition for promoting cell regeneration and preparation method and purpose thereof | |
| CN111789781A (en) | Compound peptide emulsion with effects of resisting oxidation, maintaining beauty and keeping young | |
| CN112932988B (en) | Anti-aging skin care product containing polydeoxyribonucleic acid | |
| JP2008162987A (en) | Tissue regeneration preparation comprising atrial diuretic hormone family molecule as active substance, tissue regenerating method using the preparation, hair-restoring, hair-growing and hair-developing agent and skin tissue-restoring and ameliorating agent comprising atrial diuretic hormone family molecule as active substance, and hair-restoring, hair-growing and hair-developing method and skin tissue restoring and ameliorating method using the preparation | |
| JP2009242310A (en) | Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous | |
| CN112294791A (en) | Application of astaxanthin ester in hair growth promoting product | |
| JP6296259B1 (en) | Hair restorer | |
| CN110141533A (en) | One kind going wrinkle Firm liquid and preparation method | |
| KR20160035722A (en) | A method for mucus acusta despecta sieboldiana feed live ore and cosmetic composition containing thereof | |
| RU2460514C2 (en) | Face-pack |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |